Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Voltage-gated sodium channels (VGSCs) are transmembrane proteins that play a fundamental role in the initiation and propagation of action potentials in excitable cells, including the sensory afferent nerves innervating the urinary bladder (Black and Waxman, 2013, Nature Reviews Neurology). In the bladder, specific subtypes such as NaV1.7, NaV1.8, and NaV1.9 are critical for transmitting sensory signals related to bladder filling, urgency, and pain from the peripheral tissue to the central nervous system (Yoshimura et al., 2014, Urology). Dysregulation or hyperexcitability of these channels is a hallmark of conditions like overactive bladder (OAB) and interstitial cystitis/bladder pain syndrome (IC/BPS), where increased sodium current leads to premature or exaggerated sensory signaling (Zhu et al., 2020, Frontiers in Physiology). Pharmacological intervention typically involves the use of local anesthetics or subtype-selective inhibitors to block sodium ion influx, thereby dampening the electrical activity of these afferent fibers and reducing symptoms of urgency and pain (Vertex Pharmaceuticals, 2024, Press Release). While effective, the development of these therapies must carefully manage selectivity to avoid off-target effects on NaV1.5 in the heart or NaV1.1/1.2 in the brain, which can cause significant safety issues like arrhythmias or neurological deficits (Black and Waxman, 2013, Nature Reviews Neurology).
Voltage-gated sodium channel blockers bind to the alpha subunit of the channel, physically obstructing the pore or stabilizing the inactivated state, which prevents the influx of sodium ions and inhibits the generation and propagation of action potentials in sensory afferent nerves (Black and Waxman, 2013, Nature Reviews Neurology; Yoshimura et al., 2014, Urology).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-gated sodium channel (VGSC) (VGSC).